Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test.
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
Continue to meet or exceed healthcare partners’ expectations by providing on-time test results appr...
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...